LabGenomics Co., Ltd.

₩1,894As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:084650Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (13.87%)
Div yield —
ROE (30.59%)
Medical Devices
Beta (5Y) 0.36
PE TTM —
TSR TTM (82.82%)
Mkt cap ₩28.12B
ROIC (24.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,007
5.96%
(65.70%)
Hold 6|2|1|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
26.15
28.95
31.52
34.78
19.55%
19.12%
24.23%
29.45%
Revenue₩B
3.531
3.581
3.691
3.659
6.25%
2.39%
3.38%
1.83%
Peers (US$20.73M)
Cap (US$)
PE
21.47M
—
13.18M
—
Capital
TTM
5Y
10Y
Leveragex
1.543
0.782
0.513
EBIT/Intx
3.145
0.164
0.165
Own earn%
56.41
(45.18)
(32.28)
Sh yield%
21.34
45.69
44.15
Owners
Insiders/Inst%
11.50
85.78
Short interest%
5.59
SBC / revenue%
2.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
5–13
$1 testx
—
Incr. ROIC%
4